These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9252093)

  • 21. Synthesis of 2-amido-3-hydroxypyridin-4(1H)-ones: novel iron chelators with enhanced pFe3+ values.
    Liu ZD; Piyamongkol S; Liu DY; Khodr HH; Lu SL; Hider RC
    Bioorg Med Chem; 2001 Mar; 9(3):563-73. PubMed ID: 11310590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum non-transferrin-bound iron in beta-thalassaemia major patients treated with desferrioxamine and L1.
    al-Refaie FN; Wickens DG; Wonke B; Kontoghiorghes GJ; Hoffbrand AV
    Br J Haematol; 1992 Oct; 82(2):431-6. PubMed ID: 1419825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapy.
    Devanur LD; Evans RW; Evans PJ; Hider RC
    Biochem J; 2008 Jan; 409(2):439-47. PubMed ID: 17919118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect Comparison of Both Iron Chelators on Outcomes, Iron Deposit, and Iron Transporters After Intracerebral Hemorrhage in Rats.
    Wang G; Hu W; Tang Q; Wang L; Sun XG; Chen Y; Yin Y; Xue F; Sun Z
    Mol Neurobiol; 2016 Aug; 53(6):3576-3585. PubMed ID: 26099311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and evaluation of N-basic substituted 3-hydroxypyridin-4-ones: orally active iron chelators with lysosomotrophic potential.
    Liu ZD; Khodr HH; Lu SL; Hider RC
    J Pharm Pharmacol; 2000 Mar; 52(3):263-72. PubMed ID: 10757413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PCTH: a novel orally active chelator of the aroylhydrazone class that induces iron excretion from mice.
    Wong CS; Kwok JC; Richardson DR
    Biochim Biophys Acta; 2004 Dec; 1739(1):70-80. PubMed ID: 15607119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of iron-chelator deferiprone on the in vitro growth of staphylococci.
    Kim CM; Shin SH
    J Korean Med Sci; 2009 Apr; 24(2):289-95. PubMed ID: 19399272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liquid extraction and ion-pair HPLC for determination of hydrophilic 3-hydroxypyridin-4-one iron chelators.
    Liu DY; Liu ZD; Lu SL; Hider RC
    J Pharm Biomed Anal; 1999 Dec; 21(4):759-65. PubMed ID: 10701941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of iron chelation on the in-vitro growth of Leishmania promastigotes.
    Soteriadou K; Papavassiliou P; Voyiatzaki C; Boelaert J
    J Antimicrob Chemother; 1995 Jan; 35(1):23-9. PubMed ID: 7768775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Labile plasma iron in iron overload: redox activity and susceptibility to chelation.
    Esposito BP; Breuer W; Sirankapracha P; Pootrakul P; Hershko C; Cabantchik ZI
    Blood; 2003 Oct; 102(7):2670-7. PubMed ID: 12805056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, physicochemical characterization, and biological evaluation of 2-(1'-hydroxyalkyl)-3-hydroxypyridin-4-ones: novel iron chelators with enhanced pFe(3+) values.
    Liu ZD; Khodr HH; Liu DY; Lu SL; Hider RC
    J Med Chem; 1999 Nov; 42(23):4814-23. PubMed ID: 10579844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver iron depletion and toxicity of the iron chelator deferiprone (L1, CP20) in the guinea pig.
    Wong A; Alder V; Robertson D; Papadimitriou J; Maserei J; Berdoukas V; Kontoghiorghes G; Taylor E; Baker E
    Biometals; 1997 Oct; 10(4):247-56. PubMed ID: 9353871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron stores.
    Zevin S; Link G; Grady RW; Hider RC; Peter HH; Hershko C
    Blood; 1992 Jan; 79(1):248-53. PubMed ID: 1728313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of novel 1-alkyl-3-hydroxy-2-methylpyrid-4-one chelators on uptake and release of iron from macrophages.
    Brock JH; Licéaga J; Arthur HM; Kontoghiorghes GJ
    Am J Hematol; 1990 May; 34(1):21-5. PubMed ID: 2327400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo and in vitro effects of 3-hydroxypyridin-4-one chelators on murine hemopoiesis.
    Hoyes KP; Jones HM; Abeysinghe RD; Hider RC; Porter JB
    Exp Hematol; 1993 Jan; 21(1):86-92. PubMed ID: 8417963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The hexadentate hydroxypyridinonate TREN-(Me-3,2-HOPO) is a more orally active iron chelator than its bidentate analogue.
    Yokel RA; Fredenburg AM; Durbin PW; Xu J; Rayens MK; Raymond KN
    J Pharm Sci; 2000 Apr; 89(4):545-55. PubMed ID: 10737916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation by iron loading and chelation of the uptake of non-transferrin-bound iron by human liver cells.
    Parkes JG; Randell EW; Olivieri NF; Templeton DM
    Biochim Biophys Acta; 1995 Apr; 1243(3):373-80. PubMed ID: 7727512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterisation of a novel oral iron chelator: 1-(N-Acetyl-6-Aminohexyl)-3-Hydroxy-2-Methylpyridin-4-one.
    Pangjit K; Banjerdpongchai R; Phisalaphong C; Fucharoen S; Xie YY; Lu ZD; Hider RC; Srichairatanakool S
    J Pharm Pharmacol; 2015 May; 67(5):703-13. PubMed ID: 25627251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the subacute toxicity and efficacy of 3-hydroxypyridin-4-one iron chelators in overloaded and nonoverloaded mice.
    Porter JB; Hoyes KP; Abeysinghe RD; Brooks PN; Huehns ER; Hider RC
    Blood; 1991 Nov; 78(10):2727-34. PubMed ID: 1824264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mobilization of iron by chiral and achiral anionic 3-hydroxypyrid-4-ones.
    Molenda JJ; Jones MM; Johnston DS; Walker EM; Cannon DJ
    J Med Chem; 1994 Dec; 37(25):4363-70. PubMed ID: 7996548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.